लोड हो रहा है...

Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancer

Bladder cancer is a highly recurrent disease in need of novel, durable treatment strategies. This study assessed the ability of an intravesical immunotherapy composed of a coformulation of the biopolymer chitosan with interleukin-12 (CS/IL-12) to induce systemic adaptive tumor-specific immunity. Int...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancer Immunol Immunother
मुख्य लेखकों: Smith, Sean G., Koppolu, Bhanu prasanth, Ravindranathan, Sruthi, Kurtz, Samantha L., Yang, Lirong, Katz, Matthew D., Zaharoff, David A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Springer Berlin Heidelberg 2015
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458215/
https://ncbi.nlm.nih.gov/pubmed/25754122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-015-1672-x
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!